Sandostatin® LAR®: A promising therapeutic tool in the management of acromegalic patients
- 31 August 1996
- journal article
- clinical trial
- Published by Elsevier BV in Metabolism
- Vol. 45, 67-71
- https://doi.org/10.1016/s0026-0495(96)90087-6
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- Sandostatin LAR®: Pharmacokinetics, pharmacodynamics, efficacy, and tolerability in acromegalic patientsMetabolism, 1995
- Effects of intramuscular microsphere-encapsulated octreotide on serum growth hormone, insulin-like growth factors (IGFs), free IGFs, and IGF-binding proteins in acromegalic patientsMetabolism, 1995